TCM
NVAX icon

Tradewinds Capital Management’s Novavax NVAX Stock Holding History

Tradewinds Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-611
Closed -$45K – 669
2022
Q1 		$45K Hold
611
– – 0.01% 265
2021
Q4 		$87K Buy
611
+405
+197% +$69.6K 0.01% 189
2021
Q3 		$43K Sell
206
-410
-67% -$90.4K 0.01% 265
2021
Q2 		$131K Buy
616
+410
+199% +$75.1K 0.02% 146
2021
Q1 		$37K Buy
206
+6
+3% +$1.2K 0.01% 272
2020
Q4 		$22K Hold
200
– – ﹤0.01% 313
2020
Q3 		$22K Buy
+200
New +$24.4K 0.01% 293
2018
Q1 		– Sell
-800
Closed -$20K – 694
2017
Q4 		$20K Hold
800
– – 0.01% 317
2017
Q3 		$18K Buy
+800
New +$17.9K 0.01% 319

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Tradewinds Capital Management's NVAX Position: Q2 2022 in Review

Tradewinds Capital Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 611 shares — an estimated $45K sold.

Tradewinds Capital Management first reported a position in NVAX in Q3 2017 and held it in 9 quarters. The position peaked at $131K in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Tradewinds Capital Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Tradewinds Capital Management sold 611 Novavax shares in Q2 2022, an estimated $45K.
  • Tradewinds Capital Management first reported a position in Novavax in Q3 2017 and held it in 9 quarters.
  • Tradewinds Capital Management's Novavax position peaked at $131K in Q2 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Tradewinds Capital Management's 13F filing for Q2 2022, filed 21 Jul 2022.